Committees

Committee members play a critical role in providing FDLI with subject-matter and editorial advisory expertise. Service on committees is limited to FDLI members and government employees. 

Get Involved: Become an FDLI Member

FDLI Committees

Academic Programs Committee helps FDLI support scholarship in the food and drug law field.

  • Paige Samson (Staff Liaison), FDLI
  • Dale Cooke, PhillyCooke Consulting
  • Marsha Echols, Howard University
  • Laverne Estanol, University of California-Irvine
  • Victoria W. Girard, Georgetown University
  • Lewis A. Grossman, American University
  • Sam Halabi, University of Missouri – Columbia School of Law
  • Stuart Kim, Cardinal Health, Inc
  • Dorothy Linvill-Neal, Novartis Pharmaceuticals Corporation
  • Elizabeth Richards, Latham & Watkins LLP
  • Alison Watkins, University of Maryland, Baltimore

Advertising and Promotion Conference Planning Committee helps FDLI to provide timely and relevant programming regarding advertising and promotion trends, emerging issues, and policy developments.

  • Melissa Scales (Staff Liaison), FDLI
  • Fadwa Almanakly, Bayer Healthcare Pharmaceuticals
  • Heather Banuelos, King & Spalding LLP
  • Rebecca Burnett, Framework Solutions
  • Kellie B. Combs, Ropes & Gray LLP
  • Virginia Foley, Opus Regulatory, Inc.
  • Mark Gaydos, Sanofi
  • Bryant M. Godfrey, Arnold & Porter LLP
  • Kelly F. Goldberg, PhRMA
  • Tim Kreidler, Dermira, Inc.
  • Chris Hughes, Sr., Boston Scientific Corporation
  • Daniel McHugh, Celgene Corporation
  • Cynthia L. Meyer, Kleinfeld, Kaplan & Becker, LLP
  • Lauren Miller, Otsuka America Pharmaceutical, Inc.
  • Wayne Pines, APCO Worldwide
  • Lucy Rose, Lucy Rose & Associates, LLC
  • Paul J. Savidge (Co-Chair), Spark Therapeutics
  • Dolores M. Shank-Samiec, Merck & Co., Inc.
  • Ellen Shumacher (Co-Chair), Bristol-Meyers Squibb Company

Annual Conference Planning Committee helps FDLI develop the premier conference for the food and drug law industry.

  • Laura Brown (Staff Liaison), FDLI
  • Azim Chowdhury, Keller and Heckman LLP
  • Dean R. Cirotta, EAS Consulting Group, LLC
  • James N. Czaban, DLA Piper LLP (US)
  • Kathleen Hoke, University of Maryland Carey School of Law
  • Brenda Huneycutt, FasterCures
  • Madeleine M. McDonough, Shook, Hardy & Bacon LLP
  • John A. Murphy, Biotechnology Innovation Organization
  • Adora Ndu, BioMarin Pharmaceutical
  • Amy Norris (Co-Chair), Clif Bar & Company
  • Stuart M. Pape, Polsinelli PC
  • Vernessa Pollard, McDermott Will & Emery
  • Cassie Scherer, Medtronic
  • William Schultz (Co-Chair), Zuckerman Spaeder LLP
  • Jesse J. Sevcik, Elanco Animal Health
  • Julia C. Tierney, FDA – CBER
  • José Alberto Campos Vargas, Sánchez Devanny
  • Michael Werner, Holland & Knight LLP

Audit Committee oversees and evaluates the management’s control over financial reporting. This committee is led by and reports to the FDLI Board of Directors. 

  • Hayley Carpenter (Staff Liaison), FDLI
  • Stacy L. Ehrlich (Chair), Kleinfeld, Kaplan & Becker, LLP
  • Cathy Burgess, Alston & Bird LLP
  • Neil P. Di Spirito, Epstein Becker & Green, PC
  • Stuart Pape, Polsinelli PC

Austern Writing Awards Committee fosters the next generation of professionals in the food and drug law field. 

  • Paige Samson (Staff Liaison), FDLI
  • Deborah Attwood, Steptoe & Johnson
  • Melissa Card-Abela, Michigan State University
  • Jane Kalinina, Hogan Lovells US LLP
  • Kristen Klesh, Venable LLP
  • Donnelly McDowell, Kelley Drye & Warren LLP
  • Josh Oyster, Ropes & Gray LLP
  • Sung Park, Reed Smith LLP

California Programs Planning Committee helps FDLI develop programming to be offered in California.

  • Laura Brown (Staff Liaison), FDLI
  • Khara Minter (Staff Liaison), FDLI
  • Wade Ackerman, Covington & Burling LLP
  • Afia Asamoah, Verily Life Sciences LLC
  • Heather Howell, NSF International
  • Vinita Kailasanath, Arnold & Porter LLP
  • Emily Marden, Sidley Austin LLP
  • Ian M. Pearson, Jones Day
  • Kai Peters, Gordon & Rees LLP
  • Deborah E. Tolomeo, Genentech, Inc.

Cannabis-Derived Products Committee assists FDLI with developing content and identifying stakeholders to contribute to the discussion of cannabis-derived products in the federal regulatory space.

  • Melissa Scales (Staff Liaison), FDLI
  • Linda Bentley, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Bridget C.E. Dooling, George Washington University
  • William A. Garvin, Buchanan Ingersoll & Rooney PC
  • Aidan Hampson, National Institutes of Health, National Inst. of Drug Abuse
  • Jonathan Havens, Saul Ewing Arnstein & Lehr
  • Larry K. Houck, Hyman, Phelps & McNamara, PC
  • Erika Lietzan, University of Missouri – Columbia School of Law
  • Brian J. Malkin, Arent Fox, LLP
  • Patrick Moen, Privateer Holdings
  • Heike Newman, University of Colorado
  • Jessica O’Connell, Covington & Burling LLP
  • Christopher G. Van Gundy, Sheppard Mullin Richter & Hampton LLP

Enforcement, Litigation, and Compliance Conference Planning Committee helps FDLI cover the latest trends and changes in enforcement and compliance.

  • Laura Brown (Staff Liaison), FDLI
  • Kalah Auchincloss, Greenleaf Health, Inc.
  • Erica Battaglia, Abbott Laboratories
  • Hannah Bornstein, Nixon Peabody LLP
  • Adrienne Franco Busby, Faegre Baker Daniels LLP
  • Patrick Gallagher, Duane Morris LLP
  • Jonathan Gil, Pfizer, Inc.
  • Sonali P. Gunawardhana, Shook, Hardy & Bacon LLP
  • Daniel G. Jarcho, Alston & Bird LLP
  • Howard R. Sklamberg, Akin Gump Strauss Hauer & Feld LLP
  • Michael A. Swit, Law Offices of Michael A. Swit
  • Anne K. Walsh, Hyman, Phelps & McNamara, PC
  • Jessica Zeller, FDA – ORA

Finance Committee oversees FDLI’s financial affairs, including budget formulation and execution, and investment portfolio management. This committee is led by and reports to the FDLI Board of Directors. 

  • Hayley Carpenter (Staff Liaison), FDLI
  • Frederick R. Ball (Chair), Duane Morris LLP
  • Jeffrey Francer (Board Liaison), Association for Accessible Medicines
  • Amy Norris, Clif Bar & Company
  • Peter Pitts, Center for Medicine in the Public Interest
  • Stuart TenHoor, Stuart TenHoor Legal Search

Food Advertising, Labeling, and Litigation Conference Planning Committee helps FDLI to provide updates on the most pertinent aspects and trends in advertising, labeling, and litigation. 

  • Steven Leslie (Staff Liaison), FDLI
  • August T. Horvath, Foley Hoag LLP
  • Maia C. Kats, Kaplan Fox & Kilsheimer LLP
  • Keith Matthews, Wiley Rein LLP
  • Diane C. McEnroe, Sidley Austin LLP
  • Meredith Q. Olearchik, Campbell Soup Company
  • Michael T. Roberts, UCLA School of Law
  • Ronald Y. Rothstein, Winston & Strawn LLP
  • Suzie Loonam Trigg (Chair), Haynes and Boone LLP 
  • Kurt D. Weaver, Womble Bond Dickinson (US) LLP
  • Kristi L. Wolff, Kelley Drye & Warren LLP
  • Nury Yoo, Keller and Heckman LLP

Food and Drug Law Journal Editorial Advisory Board provides peer review of manuscript submissions, advises on content, and serves as a resource for our student editors at Georgetown University Law Center.

  • Anthony J. Anscombe, Steptoe & Johnson LLP
  • Nigel Barrella, Law Office of Nigel Barrella
  • Kenita Barrow, Otsuka America Pharmaceutical, Inc.
  • Laurie J. Beyranevand, Vermont Law School
  • Barbara A. Binzak Blumenfeld, Buchanan Ingersoll & Rooney PC
  • Marie Boyd, University of South Carolina
  • Nathan Brown, Akin Gump Strauss Hauer & Feld LLP
  • Catherine A. Clements, Eli Lilly and Company
  • Carl Fischer, Becton Dickinson
  • Ralph Hall, University of Minnesota
  • Peter Barton Hutt, Covington & Burling LLP
  • Erica Michele Jackson, K&L Gates LLP
  • William M. Janssen, Charleston School of Law
  • John Johnson, FDAImports.com, LLC/ Benjamin L. England & Associates LLC
  • Alan C. Katz, toXcel, LLC
  • Sari Bourne Kaplan, Genentech, Inc.
  • Sara Wexler Koblitz, Hyman, Phelps & McNamara, PC
  • Hilary Lewis, Morgan, Lewis & Bockius LLP
  • Priya Malavika Mannan, Novartis Pharmaceuticals Corporation
  • Alexandra Marzelli, FDA – OC
  • J.R. McNair, Winston & Strawn LLP
  • Alan Minsk, Arnall Golden Gregory, LLP
  • Nicole E. Negowetti, Harvard Law School
  • James T. O’Reilly, University of Cincinnati
  • Bruce Patsner, University of Houston
  • Sandra Retzky, FDA – CTP
  • Jessica Ringel, King & Spalding LLP
  • Melissa B. Runsten, Debevoise & Plimpton, LLP
  • Marc Scheineson, Alston & Bird LLP
  • Jodi Schipper, FDA – CDER
  • Shy Shorer, National Institutes of Health
  • David C. Spangler, Consumer Healthcare Products Association (CHPA)
  • Andrew Wasson, Haug Partners LLP
  • Emily Wright, Pfizer, Inc.
  • Lowell Zeta, Hogan Lovells US LLP
  • Patricia Zettler, Georgia State University

Food Enforcement and Compliance Conference Planning Committee helps FDLI to cover recent changes and updates in food enforcement and compliance. 

  • Paige Samson (Staff Liaison), FDLI
  • Steve H. Armstrong, EAS Consulting Group, LLC
  • Elizabeth Barr Fawell, Hogan Lovells US LLP
  • Trevor Findley, USDA
  • Megan L. Olsen, Council for Responsible Nutrition
  • John M. Packman (Chair), DLA Piper LLP (US)
  • Jenna Robeson, Plated
  • Sarah Roller, Kelley Drye & Warren LLP
  • Jason W. Sapsin, Faegre Baker Daniels LLP
  • Smitha G. Stansbury, King & Spalding LLP

Medical Products Committee helps FDLI provide programming to meet the needs of the medical products community.  

  • Melissa Scales (Staff Liaison), FDLI
  • Kate Cook, Greenleaf Health, Inc.
  • Philip R. Desjardins, Johnson & Johnson
  • Maya P. Florence, Skadden, Arps, Slate, Meagher & Flom LLP
  • Paul Gadiock, Wilson Sonsini Goodrich & Rosati
  • Melanie Katrice Gross, Genentech, Inc.
  • Robert Guzman, Thompson Hine LLP
  • Todd H. Halpern, Venable LLP
  • Charles Jolly, Baker Donelson 
  • Chad A. Landmon, Axinn, Veltrop & Harkrider LLP
  • Mark C. Levy, Eckert Seamans Cherin & Mellott, LLC
  • Deborah Livornese, Hyman, Phelps & McNamara, PC
  • Eric Marshall, Leavitt Partners, LLC
  • Daniel Orr, Womble Bond Dickinson (US) LLP
  • Lance L. Shea, BakerHostetler
  • Kirke Weaver, Merck & Co., Inc.

New to Food and Drug Law Planning Committee assists FDLI in creating educational programming and networking opportunities for those new to food and drug law.

  • Paige Samson (Staff Liaison), FDLI
  • Amy Arthur, Junior Associate, Pinney Associates, Inc.
  • Shelby Buettner, Attorney, FDA – OC
  • Ariella Cohen, Associate, Health Care Products, The Pew Charitable Trusts
  • Delia Deschaine, Senior Associate, Hogan Lovells US LLP
  • Steven Gonzalez, Associate, Ropes & Gray
  • Rachael E. Hunt, Attorney, Hyman, Phelps & McNamara, PC
  • Elizabeth Mulkey, Associate, Goodwin Procter LLP
  • Megan Robertson, Associate, Epstein Becker & Green, PC
  • Shane Schwartz, Corporate Attorney, Otsuka America Pharmaceuticals, Inc.
  • Steven Tjoe, Associate, Goodwin Procter LLP

Patient Organization Engagement Committee assists FDLI by creating innovative introductory course offerings for patient organizations.

  • Paige Samson (Staff Liaison), FDLI
  • Ryan Hohman, Friends of Cancer Research
  • Brenda Huneycutt, FasterCures
  • Debra Lappin, Faegre Baker Daniels Consulting
  • James Valentine, Hyman, Phelps & McNamara, PC
  • Laura Wingate, Crohn’s & Colitis Foundation

Publications Advisory Board provides strategic input on developing book projects, identifying editors and authors, and the overall content of the FDLI publications program.

  • Ricardo Carvajal, Hyman, Phelps & McNamara, PC
  • Joanne Hawana, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Marian J. Lee, Gibson Dunn & Crutcher LLP
  • Laurie Lenkel, FDA – OC
  • Lynn C. Tyler, Barnes & Thornburg LLP

Publications Peer Review Committee provides manuscript review and editorial feedback for Update magazine, electronic resources, and book chapters. 

  • Carolyn Alenci, Duane Morris LLP
  • Deirdre J. Boling-Lewis, Sincerus Pharmaceuticals, Inc.
  • Jacqueline Chan, Kleinfeld, Kaplan & Becker, LLP
  • Royce DuBiner, McGuireWoods LLP
  • Avia Dunn, Skadden, Arps, Slate, Meagher & Flom LLP
  • Julie Finegan, FDA – OC
  • Ryan M. Fournier, Morgan, Lewis & Bockius LLP
  • Jennifer Fulford, toXcel, LLC
  • Ann Marie Gaitan, Diversey
  • Abraham Gitterman, Arnold & Porter LLP
  • Colleen M. Heisey, Jones Day
  • Emily Hussey, Reed Smith LLP
  • Darshan Kulkarni, Kulkarni Law Firm
  • Susan Lee, Hogan Lovells US LLP
  • Suzanne Forbis Mack, Pepper Hamilton LLP
  • Eileen M. McMahon, Torys LLP
  • Beth G. Oliva, Fox Rothschild LLP
  • Caitlyn Ozier, King & Spalding LLP
  • Kai Peters, Gordon & Rees LLP
  • Tyler M. Scandalios, FDAImports.com, LLC / Benjamin L. England & Associates, LLC
  • Michael K. Stern, Covington & Burling LLP
  • Eli Zachary Tomar, Akin Gump Strauss Hauer & Feld LLP

Tobacco and Nicotine Products Committee ensures that tobacco programs bring diverse stakeholders together to have high-level discussions on tobacco products regulation and policy.  

*Denotes members of the Public Health Sub-Committee

  • Steven Leslie (Staff Liaison), FDLI
  • David Abrams, New York University
  • Scott D. Ballin, Health Policy Consultant
  • James Baumberger, American Academy of Pediatrics*
  • Don Ray Becker, Turning Point Brands, Inc.
  • Aruni Bhatnagar, University of Louisville and American Heart Association*
  • Tara Lin Couch, EAS Consulting Group, LLC
  • Cliff Douglas, American Cancer Society, Inc*
  • Carole B. Folmar, ITG Brands
  • Stacey Gagosian, Truth Initiative | Co-Chair, Public Health Sub-Committee*                         
  • Robyn Gougelet, Pinney Associates, Inc
  • Ashley Gould, JUUL Labs
  • Bryan M. Haynes, Troutman Sanders LLP
  • Dennis Henigan, Campaign for Tobacco Free Kids | Co-Chair, Public Health Sub-Committee*
  • Desmond Jenson, Tobacco Control Legal Consortium at the Public Health Law Center*
  • Eshael M. Johnson, FDA – CTP
  • Eric N. Lindblom, O’Neill Institute for National and Global Health Law, Georgetown Law
  • Jack Marshall, Altria Client Services LLC
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • Barry Schaevitz, Fox Rothschild LLP
  • Valerie B. Solomon, RAI Services Company

Webinar Programs Committee advises FDLI in formulating and implementing webinars about law, regulation and policy affecting food and dietary supplements, tobacco and nicotine, and medical products. 

  • Khara L. Minter (Staff Liaison), FDLI
  • Melissa Scales (Staff Liaison), FDLI
  • Nathan A. Beaver, Foley & Lardner LLP
  • Sharon M. Bradley, Mylan Pharmaceuticals, Inc.
  • Karen Corallo, Skadden, Arps, Slate, Meagher & Flom LLP
  • Scott L. Cunningham, Covington & Burling LLP
  • John R. Finley, AIS Healthcare
  • Jack C. Garvey, Compliance Architects
  • Rebecca Jones McKnight, DLA Piper LLP (US)
  • Rikin S. Mehta, Aquestive Therapeutics
  • Eve Pelonis, Keller and Heckman LLP
  • Jill E. Sackman, Exponent, Inc
  • Barrett Tenbarge, Latham & Watkins LLP
  • Rachel Turow, TEVA Pharmaceuticals USA, Inc.
  • Carolina Wirth, Porzio, Bromberg & Newman, P.C.